Stock AMYT AMRYT PHARMA PLC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Amryt Pharma plc

Equities

AMYT

US03217L1061

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Chiesi Global Rare Diseases Announces Health Canada Approval of MYALEPTA™ (metreleptin for injection) for the Treatment of Patients with Lipodystrophy
AQ
Key Senior Members of Former Amryt Pharma Leadership Team join Poolbeg Pharma
AQ
Amryt Pharma plc(NasdaqGS:AMYT) dropped from S&P Global BMI Index
CI
2022 for Chiesi, The Group's international growth continues
AQ
Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma Plc
GL
Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma Plc
GL
Amryt Pharma plc(NasdaqGS:AMYT) dropped from NASDAQ Composite Index
CI
Chiesi Farmaceutici S.p.A. completed the acquisition of Amryt Pharma plc from Athyrium Capital Management, LP, Highbridge Capital Management, LLC, Joe Wiley, Rory Nealon, Ray Stafford and others.
CI
2022 for Chiesi: The Group’s international growth continues
AQ
Amryt Pharma Plc - High Court of Justice of England and Wales Sanctions Scheme of Arrangement
AQ
High Court of Justice of England and Wales Sanctions Scheme of Arrangement
GL
High Court of Justice of England and Wales Sanctions Scheme of Arrangement
AQ
Amryt Pharma's Shareholders Approve Acquisition by Chiesi Farmaceutici
MT
Amryt Pharma Shareholders approve acquisition of Amryt Pharma by Chiesi Farmaceutici
GL
Amryt Pharma plc’s Equity Buyback announced on March 9, 2022, has expired.
CI
AMYT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Amryt Pharma Plc Is Fair to Shareholders
BU
AMRYT PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Amryt Pharma Plc - AMYT
BU
AMRYT PUBLISHES SCHEME CIRCULAR AND ANNOUNCES THE SHAREHOLDER MEETINGS TO CONSIDER AND VOTE ON THE CHIESI ACQUISITION WILL BE HELD ON MARCH 22, 2023
GL
AMRYT PUBLISHES SCHEME CIRCULAR AND ANNOUNCES THE SHAREHOLDER MEETINGS TO CONSIDER AND VOTE ON THE CHIESI ACQUISITION WILL BE HELD ON MARCH 22, 2023
AQ
HC Wainwright Downgrades Amryt Pharma to Neutral From Buy, Cuts Price Target to $14.50 From $18
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AMYT Stock
  4. News Amryt Pharma plc